Black Diamond Therapeutics, Inc.

NASDAQ:BDTX

Biotechnology

Healthcare
$1.43 -2.40%

-$0.04 today

Market cap
$82.18M
Beta
3.23
P/E (TTM)
-2.2
EPS (TTM)
-$0.75
52W Low $1.62High $4.94

Volume 0.60M

Average 1.31M

Price history

Black Diamond Therapeutics, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-63.24%

Period high

$3.89

Period low

$1.43

Latest

$1.43

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
8-KNov 10, 2026Nov 10, 2026
10-QNov 10, 2026Nov 10, 2026
4Sep 21, 2026Sep 21, 2026
4Sep 21, 2026Sep 21, 2026
8-KAug 5, 2026Aug 5, 2026
10-QAug 5, 2026Aug 5, 2026
SC 13GJul 27, 2026Jul 27, 2026
SC 13G/AJul 8, 2026Jul 8, 2026
8-KJun 29, 2026Jun 29, 2026
4Jun 29, 2026Jun 29, 2026
4Jun 29, 2026Jun 29, 2026
4Jun 29, 2026Jun 29, 2026
4Jun 29, 2026Jun 29, 2026
4Jun 29, 2026Jun 29, 2026
4Jun 29, 2026Jun 29, 2026

Competitors

Who does Black Diamond Therapeutics, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about BDTX's filings, answered from its disclosures.

What is the latest BDTX filing?

The latest filing shown is 8-K dated Nov 10, 2026.

How many recent filings does BDTX have?

Intrinsic Alpha currently shows 20 recent filings for BDTX.